GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » NKY Medical Holdings Ltd (SZSE:300109) » Definitions » EV-to-Revenue

NKY Medical Holdings (SZSE:300109) EV-to-Revenue : 4.31 (As of May. 11, 2024)


View and export this data going back to 2010. Start your Free Trial

What is NKY Medical Holdings EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, NKY Medical Holdings's enterprise value is ¥6,967 Mil. NKY Medical Holdings's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 was ¥1,615 Mil. Therefore, NKY Medical Holdings's EV-to-Revenue for today is 4.31.

The historical rank and industry rank for NKY Medical Holdings's EV-to-Revenue or its related term are showing as below:

SZSE:300109' s EV-to-Revenue Range Over the Past 10 Years
Min: 2.71   Med: 6.52   Max: 54.47
Current: 4.53

During the past 13 years, the highest EV-to-Revenue of NKY Medical Holdings was 54.47. The lowest was 2.71. And the median was 6.52.

SZSE:300109's EV-to-Revenue is ranked worse than
73.22% of 1027 companies
in the Drug Manufacturers industry
Industry Median: 2.4 vs SZSE:300109: 4.53

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-05-11), NKY Medical Holdings's stock price is ¥22.29. NKY Medical Holdings's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 was ¥4.99. Therefore, NKY Medical Holdings's PS Ratio for today is 4.46.


NKY Medical Holdings EV-to-Revenue Historical Data

The historical data trend for NKY Medical Holdings's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NKY Medical Holdings EV-to-Revenue Chart

NKY Medical Holdings Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 6.43 5.06 5.09 4.92 3.49

NKY Medical Holdings Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EV-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.80 4.92 3.94 3.49 3.64

Competitive Comparison of NKY Medical Holdings's EV-to-Revenue

For the Drug Manufacturers - General subindustry, NKY Medical Holdings's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


NKY Medical Holdings's EV-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, NKY Medical Holdings's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where NKY Medical Holdings's EV-to-Revenue falls into.



NKY Medical Holdings EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

NKY Medical Holdings's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=6967.412/1615.102
=4.31

NKY Medical Holdings's current Enterprise Value is ¥6,967 Mil.
NKY Medical Holdings's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥1,615 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


NKY Medical Holdings  (SZSE:300109) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

NKY Medical Holdings's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=22.29/4.994
=4.46

NKY Medical Holdings's share price for today is ¥22.29.
NKY Medical Holdings's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥4.99.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


NKY Medical Holdings EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of NKY Medical Holdings's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


NKY Medical Holdings (SZSE:300109) Business Description

Traded in Other Exchanges
N/A
Address
No.9 Zhongshan Road, Boai county, Jiaozuo, Henan, CHN, 454450
NKY Medical Holdings Ltd develops and manufactures polyvinylpyrrolidone (PVP) series products in China. Its products can be used in Pharmaceutical accessories, hair gel, wine products stabilizer, water treatment, glue stick, and oral care products.

NKY Medical Holdings (SZSE:300109) Headlines

No Headlines